Literature DB >> 30364909

Antidepressant use in older inpatients: current situation and application of the revised STOPP criteria.

Lynn Gers1, Mirko Petrovic2, Stany Perkisas1, Maurits Vandewoude3.   

Abstract

OBJECTIVES: Antidepressant use increases as age rises. Moreover, older patients are more sensitive to side effects and drug interactions. This descriptive study aims to map antidepressant use among patients at the geriatrics department of a university hospital and to evaluate whether prescribing happens in an evidence-based manner.
METHODS: Patients aged 75 years and over, admitted to the geriatrics department of the Middelheim Hospital in Antwerp between February and July 2017 were included. We checked whether they took antidepressants, which types and doses were prescribed, who prescribed the antidepressants, and whether prescribing was in concordance with the revised STOPP (Screening Tool of Older People's Prescriptions) criteria.
RESULTS: Out of the 239 included patients, 61 were found to use antidepressants, with depression being the most important indication. General practitioners appeared to be the most frequent prescribers. Trazodone was the most prescribed antidepressant and was often used for sleeping disorders. Antidepressants were taken longer than recommended in almost one out of five cases. Patients with diabetes and renal insufficiency were prescribed antidepressants less frequently. Only 2.8% of the study participants were prescribed antidepressants for anxiety disorders.
CONCLUSION: We can conclude that prescription of antidepressants in older patients at the geriatrics department is often not evidence based. Clear guidelines may offer a solution; therefore more studies are needed on antidepressant use in older patients.

Entities:  

Keywords:  antidepressants; elderly; polypharmacy; revised Screening Tool of Older People’s Prescriptions criteria

Year:  2018        PMID: 30364909      PMCID: PMC6199683          DOI: 10.1177/2042098618778974

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  24 in total

1.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

Authors:  R J Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Diabetes Care       Date:  2001-06       Impact factor: 19.112

4.  Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies.

Authors:  Michael J Fischer; Dawei Xie; Neil Jordan; Willem J Kop; Marie Krousel-Wood; Manjula Kurella Tamura; John W Kusek; Virginia Ford; Leigh K Rosen; Louise Strauss; Valerie L Teal; Kristine Yaffe; Neil R Powe; James P Lash
Journal:  Am J Kidney Dis       Date:  2012-04-11       Impact factor: 8.860

5.  Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression.

Authors:  Jay A Brieler; Patrick J Lustman; Jeffrey F Scherrer; Joanne Salas; F David Schneider
Journal:  Fam Pract       Date:  2016-01-07       Impact factor: 2.267

Review 6.  Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies.

Authors:  B Hill-Taylor; K A Walsh; S Stewart; J Hayden; S Byrne; I S Sketris
Journal:  J Clin Pharm Ther       Date:  2016-03-17       Impact factor: 2.512

7.  Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study.

Authors:  Einstein F Camargos; Luciana L Louzada; Juliana L Quintas; Janeth O S Naves; Fernando M Louzada; Otávio T Nóbrega
Journal:  Am J Geriatr Psychiatry       Date:  2014-01-04       Impact factor: 4.105

Review 8.  Risk factors for anxiety and depression in the elderly: a review.

Authors:  Dagmar Vink; Marja J Aartsen; Robert A Schoevers
Journal:  J Affect Disord       Date:  2007-08-17       Impact factor: 4.839

9.  Pharmacological treatment of neuropathic pain in older persons.

Authors:  Clair Haslam; Turo Nurmikko
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trial.

Authors:  Christin Löffler; Eva Drewelow; Susanne D Paschka; Martina Frankenstein; Julia Eger; Lisa Jatsch; Emil C Reisinger; Johannes F Hallauer; Bernd Drewelow; Karen Heidorn; Helmut Schröder; Anja Wollny; Günther Kundt; Christian Schmidt; Attila Altiner
Journal:  Implement Sci       Date:  2014-10-06       Impact factor: 7.327

View more
  5 in total

1.  Antidepressant prescriptions and adherence in primary care in India: Insights from a cluster randomized control trial.

Authors:  Aravind Pillai; Katherine M Keyes; Ezra Susser
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

2.  'Never change a winning team': GPs' perspectives on discontinuation of long-term antidepressants.

Authors:  Van Leeuwen Ellen; Sibyl Anthierens; Mieke L van Driel; An De Sutter; Evelien van den Branden; Thierry Christiaens
Journal:  Scand J Prim Health Care       Date:  2021-12-11       Impact factor: 2.581

3.  Prescribing behavior of antidepressants for depressive disorders: A systematic review.

Authors:  Mary K Lam; Lawrence T Lam; Kerryn Butler-Henderson; Jonathan King; Tahnee Clark; Peta Slocombe; Katherine Dimarco; Wendell Cockshaw
Journal:  Front Psychiatry       Date:  2022-09-09       Impact factor: 5.435

4.  Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use.

Authors:  Dee Mangin; Doron Garfinkel
Journal:  Ther Adv Drug Saf       Date:  2019-10-21

5.  Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA).

Authors:  Natasha Slater; Simon White; Martin Frisher
Journal:  BMJ Open       Date:  2020-09-14       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.